Document is current

Any future updates will be listed below

A 5-year recurrence-free survivor with over ten colorectal liver metastases undergoing FOLFOX plus bevacizumab followed by two-stage hepatectomy

Crossref DOI link: https://doi.org/10.1186/s40792-015-0113-6

Published Online: 2015-10-29

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark